Mark Germain

Mark S.
Germain was the founder of Niagen Bioscience, Inc. (1999, Independent Non-Executive Director) and The Aentib Group (2014, Managing Director).
Current jobs include Chairman at Amphioxus Cell Technologies, Inc., Chairman at Scinai Immunotherapeutics Ltd. (2019), Director at Omnimmune Corp.
(2006), Managing Director at The Olmsted Group, and Managing Director at The Aentib Group, Inc. (2014).
Former jobs include Chairman at Stem Cell Innovations, Inc., Chairman at Collexis Holdings, Inc., Chairman at Omnimmune Holdings, Inc., Director at Interferon Sciences, Inc. (2006), Director at Wellsford Real Properties, Inc., Independent Director at Pluri, Inc. (2007-2022), Director at Intellect Neurosciences, Inc., Director at ChromaDex, Inc. (1992-2008), Director at Reis, Inc. (1997-2008), Trustee at Wellsford Residential Property Trust (1992-1997), and Vice President-Product Support at Nortrax, Inc. Education includes a graduate degree from New York University School of Law (1975).